vs
NovoCure Ltd（NVCR）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
NovoCure Ltd的季度营收约是STURM RUGER & CO INC的1.2倍（$174.1M vs $151.1M），NovoCure Ltd同比增速更快（12.3% vs 3.6%），过去两年NovoCure Ltd的营收复合增速更高（7.6% vs 5.1%）
NovoCure Ltd是一家全球肿瘤医疗企业，专注研发肿瘤治疗电场（TTFields）技术，推出可穿戴非侵入式癌症治疗设备，已获批用于胶质母细胞瘤、恶性胸膜间皮瘤、非小细胞肺癌等多个癌种，业务覆盖北美、欧洲及亚太地区。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
NVCR vs RGR — 直观对比
营收规模更大
NVCR
是对方的1.2倍
$151.1M
营收增速更快
NVCR
高出8.7%
3.6%
两年增速更快
NVCR
近两年复合增速
5.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $174.1M | $151.1M |
| 净利润 | $-71.1M | — |
| 毛利率 | 77.6% | 17.8% |
| 营业利润率 | — | 2.3% |
| 净利率 | -40.9% | — |
| 营收同比 | 12.3% | 3.6% |
| 净利润同比 | -107.3% | — |
| 每股收益（稀释后） | — | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVCRRGR
| Q1 26 | $174.1M | — | ||
| Q4 25 | $174.3M | $151.1M | ||
| Q3 25 | $167.2M | $126.8M | ||
| Q2 25 | $158.8M | $132.5M | ||
| Q1 25 | $155.0M | $135.7M | ||
| Q4 24 | $161.3M | $145.8M | ||
| Q3 24 | $155.1M | $122.3M | ||
| Q2 24 | $150.4M | $130.8M |
净利润NVCRRGR
| Q1 26 | $-71.1M | — | ||
| Q4 25 | $-24.5M | — | ||
| Q3 25 | $-37.3M | $1.6M | ||
| Q2 25 | $-40.1M | $-17.2M | ||
| Q1 25 | $-34.3M | $7.8M | ||
| Q4 24 | $-65.9M | — | ||
| Q3 24 | $-30.6M | $4.7M | ||
| Q2 24 | $-33.4M | $8.3M |
毛利率NVCRRGR
| Q1 26 | 77.6% | — | ||
| Q4 25 | 75.8% | 17.8% | ||
| Q3 25 | 73.2% | 15.1% | ||
| Q2 25 | 73.9% | 3.9% | ||
| Q1 25 | 75.1% | 22.0% | ||
| Q4 24 | 79.2% | 22.8% | ||
| Q3 24 | 77.2% | 18.5% | ||
| Q2 24 | 77.0% | 22.3% |
营业利润率NVCRRGR
| Q1 26 | — | — | ||
| Q4 25 | -23.2% | 2.3% | ||
| Q3 25 | -21.5% | -2.7% | ||
| Q2 25 | -24.9% | -15.6% | ||
| Q1 25 | -24.4% | 6.2% | ||
| Q4 24 | -39.3% | 7.8% | ||
| Q3 24 | -20.7% | 3.1% | ||
| Q2 24 | -22.3% | 6.9% |
净利率NVCRRGR
| Q1 26 | -40.9% | — | ||
| Q4 25 | -14.1% | — | ||
| Q3 25 | -22.3% | 1.2% | ||
| Q2 25 | -25.3% | -13.0% | ||
| Q1 25 | -22.1% | 5.7% | ||
| Q4 24 | -40.9% | — | ||
| Q3 24 | -19.7% | 3.9% | ||
| Q2 24 | -22.2% | 6.3% |
每股收益（稀释后）NVCRRGR
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | $0.22 | ||
| Q3 25 | $-0.33 | $0.10 | ||
| Q2 25 | $-0.36 | $-1.05 | ||
| Q1 25 | $-0.31 | $0.46 | ||
| Q4 24 | $-0.61 | $0.62 | ||
| Q3 24 | $-0.28 | $0.28 | ||
| Q2 24 | $-0.31 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $432.0M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $330.7M | $283.8M |
| 总资产 | $787.9M | $342.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVCRRGR
| Q1 26 | $432.0M | — | ||
| Q4 25 | $93.5M | $92.5M | ||
| Q3 25 | $342.1M | $80.8M | ||
| Q2 25 | $149.6M | $101.4M | ||
| Q1 25 | $127.3M | $108.3M | ||
| Q4 24 | $163.8M | $105.5M | ||
| Q3 24 | $185.4M | $96.0M | ||
| Q2 24 | $164.8M | $105.6M |
股东权益NVCRRGR
| Q1 26 | $330.7M | — | ||
| Q4 25 | $340.5M | $283.8M | ||
| Q3 25 | $341.3M | $279.6M | ||
| Q2 25 | $349.4M | $289.3M | ||
| Q1 25 | $362.0M | $321.5M | ||
| Q4 24 | $360.2M | $319.6M | ||
| Q3 24 | $360.8M | $314.9M | ||
| Q2 24 | $361.8M | $321.5M |
总资产NVCRRGR
| Q1 26 | $787.9M | — | ||
| Q4 25 | $804.3M | $342.0M | ||
| Q3 25 | $1.4B | $342.3M | ||
| Q2 25 | $1.2B | $349.5M | ||
| Q1 25 | $1.2B | $379.0M | ||
| Q4 24 | $1.2B | $384.0M | ||
| Q3 24 | $1.2B | $373.5M | ||
| Q2 24 | $1.2B | $376.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $15.5M |
| 自由现金流经营现金流 - 资本支出 | — | $12.3M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | — | 2.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $38.5M |
8季度趋势，按日历期对齐
经营现金流NVCRRGR
| Q1 26 | — | — | ||
| Q4 25 | $-18.0M | $15.5M | ||
| Q3 25 | $20.6M | $12.9M | ||
| Q2 25 | $-15.9M | $14.7M | ||
| Q1 25 | $-35.7M | $11.1M | ||
| Q4 24 | $-3.5M | $20.0M | ||
| Q3 24 | $10.4M | $9.4M | ||
| Q2 24 | $-1.7M | $18.7M |
自由现金流NVCRRGR
| Q1 26 | — | — | ||
| Q4 25 | $-22.9M | $12.3M | ||
| Q3 25 | $14.9M | $7.0M | ||
| Q2 25 | $-21.4M | $9.1M | ||
| Q1 25 | $-46.3M | $10.0M | ||
| Q4 24 | $-12.4M | $16.4M | ||
| Q3 24 | $-307.0K | $2.6M | ||
| Q2 24 | $-13.2M | $10.1M |
自由现金流率NVCRRGR
| Q1 26 | — | — | ||
| Q4 25 | -13.1% | 8.2% | ||
| Q3 25 | 8.9% | 5.5% | ||
| Q2 25 | -13.5% | 6.9% | ||
| Q1 25 | -29.9% | 7.4% | ||
| Q4 24 | -7.7% | 11.2% | ||
| Q3 24 | -0.2% | 2.1% | ||
| Q2 24 | -8.8% | 7.7% |
资本支出强度NVCRRGR
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | 2.1% | ||
| Q3 25 | 3.4% | 4.6% | ||
| Q2 25 | 3.5% | 4.2% | ||
| Q1 25 | 6.8% | 0.8% | ||
| Q4 24 | 5.5% | 2.5% | ||
| Q3 24 | 6.9% | 5.5% | ||
| Q2 24 | 7.6% | 6.6% |
现金转化率NVCRRGR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVCR
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
